Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.
Broad-market heuristics · Not a buy/sell signal
Valuation and growth
Valuation
Growth
Negative FCF, no valuation support
Not enough quarterly data
for a 1-year trend
Below 2%, essentially flat
FCF negative, burning cash after capex
Business Quality & Capital Allocation
Shrinking >2%, active buybacks
Contracted >2pp, margin pressure
Positive debt with no FCF to service it
Hongchang International Co. (HCIL) quality: score, margins and returns
Hongchang International Co. (HCIL) scores 10/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 5 metrics each scored 0 to 100. Every metric is computed from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Hongchang International Co. (HCIL) a high-quality business?+
Hongchang International Co. scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 5 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.
What does Hongchang International Co.'s quality score measure?+
Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from HCIL's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Hongchang International Co. scores well and where it falls behind.
SourceQuality score computed from the 10-Q filed 11 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.
Fiscal year ends Mar. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.
Peers
Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with HCIL
Spot a number that looks wrong? Check it in HCIL's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing HCIL
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.